Coave Therapeutics ('Coave'), a company pioneering the future of genetic medicines, today announces the evolution of its ...

Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi's M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking ...

Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the ...

Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

The NFL has put its coaching accelerator program designed to bolster diversity efforts on hold. It makes the NFL look weak ...

The NFL has put its coaching accelerator program designed to bolster diversity efforts on hold. It makes the NFL look weak ...

The University of Minnesota Medical School and Fairview are expanding rural physician training in the state with a new residency program. The Grand Itasca Clinic & Hospital Rural Family Medicine ...

Novo Nordisk A/S' CEO transition sparks governance concerns, but internal succession ensures stability. Click for my updated ...

In a letter addressed to President Vincent Price, the chairmen alleged the partnership with Wuhan University “creates a ...

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society (ATS) 2025 International Conference.

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

These drugs target some of the most pressing cancer types, including multiple myeloma, breast cancer, and bladder cancer ...